Literature DB >> 8576157

Signal transduction by CD28 costimulatory receptor on T cells. B7-1 and B7-2 regulation of tyrosine kinase adaptor molecules.

J A Nunès1, A Truneh, D Olive, D A Cantrell.   

Abstract

This study compares the biochemical responses in T cells activated with the CD28 ligands B7-1 and B7-2. The patterns of tyrosine phosphorylation induced in T cells by these two CD28 ligands are identical, but clearly different from the tyrosine phosphorylation induced by the T cell receptor (TCR). The TCR regulates protein complexes mediated by the adapter Grb2 both in vivo and in vitro. In contrast, there is no apparent regulation of in vivo Grb2 complexes in response to B7-1 or B7-2. Rather, B7-1 and B7-2 both induce tyrosine phosphorylation of a different adaptor protein, p62. The regulation of p62 is a unique CD28 response that is not shared with the TCR. These data indicate that B7-1 and B7-2 induce identical tyrosine kinase signal transduction pathways. The data show also that the TCR and CD28 couple to different adapter proteins, which could explain the divergence of TCR and CD28 signal transduction pathways during T cell activation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8576157     DOI: 10.1074/jbc.271.3.1591

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

Review 1.  Small GTPases in lymphocyte biology: Rho proteins take center stage.

Authors:  S Henning; S Cleverley
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Does computational biology help us to understand the molecular phylogenetics and evolution of cluster of differentiation (CD) proteins?

Authors:  Chiranjib Chakraborty; C George Priya Doss; Ritu Sharma; Subrata Sahana; Thumpi S Nair
Journal:  Protein J       Date:  2013-02       Impact factor: 2.371

3.  CD86 gene variants and susceptibility to pancreatic cancer.

Authors:  Honggang Xiang; Wei Zhao; Yanping Sun; Winnie Qian; Junjie Xing; Yujia Zhou; Jun Yao; Jian Xu; Yi Wang; Houshan Yao; Zhiqian Hu
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-21       Impact factor: 4.553

Review 4.  CD28/CTLA-4 and CD80/CD86 families: signaling and function.

Authors:  J M Slavik; J E Hutchcroft; B E Bierer
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

5.  Expression of CD80 (B7/BB-1) and CD28 in human white blood cells treated with urocanic acid.

Authors:  J K Laihia; J Uksila; M Luhtala; C T Jansén
Journal:  Arch Dermatol Res       Date:  1996-09       Impact factor: 3.017

Review 6.  CD28: a signalling perspective.

Authors:  S G Ward
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

7.  Evidence that a kinase distinct from protein kinase C and phosphatidylinositol 3-kinase mediates ligation-dependent serine/threonine phosphorylation of the T-lymphocyte co-stimulatory molecule CD28.

Authors:  R V Parry; D Olive; J Westwick; D M Sansom; S G Ward
Journal:  Biochem J       Date:  1997-08-15       Impact factor: 3.857

8.  Dok1 and Dok2 proteins regulate natural killer cell development and function.

Authors:  Javier Celis-Gutierrez; Marilyn Boyron; Thierry Walzer; Pier Paolo Pandolfi; Stipan Jonjić; Daniel Olive; Marc Dalod; Eric Vivier; Jacques A Nunès
Journal:  EMBO J       Date:  2014-06-24       Impact factor: 11.598

9.  Dok-4 is a novel negative regulator of T cell activation.

Authors:  Audrey Gérard; Marguerite Ghiotto; Camille Fos; Geoffrey Guittard; Daniel Compagno; Anne Galy; Serge Lemay; Daniel Olive; Jacques A Nunès
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

Review 10.  T cell vaccinology: exploring the known unknowns.

Authors:  Matt A Burchill; Beth A Tamburini; Nathan D Pennock; Jason T White; Jonathan S Kurche; Ross M Kedl
Journal:  Vaccine       Date:  2012-11-06       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.